Looking for distribution partners in Europe, Asia and the US for highly reliable molecular in vitro diagnostic (IVD) test for screening, triage and follow-up care in cervical cancer diagnostics


A young German SME specialized in molecular biology and cancer diagnostics has developed a fast and reliable diagnostic test based on epigenetic changes (DNA methylation) which are characteristic for cancer cells. These highly informative biomarkers validated in clinical trials and applicable for early detection of cervical cancer. Corresponding marker sets for head-and-neck tumor and ovarian cancer are also validated. Seeking medical partners for licensing and technical cooperation agreements.
ACTIS Cooperación Tecnológica
Enlace: Looking for distribution partners in Europe, Asia and the US for highly reliable molecular in vitro diagnostic (IVD) test for screening, triage and follow-up care in cervical cancer diagnostics

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.

ACEPTAR
Aviso de cookies